Biogen Inc.
BIIB
$129.44
$3.853.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.59% | -1.62% | -3.86% | -3.00% | -4.37% |
| Total Other Revenue | -- | -- | -- | -- | -105.17% |
| Total Revenue | 1.59% | -1.62% | -3.86% | -3.00% | -4.37% |
| Cost of Revenue | -2.82% | -12.28% | -9.21% | -0.78% | 8.30% |
| Gross Profit | 3.02% | 2.07% | -2.09% | -3.67% | -7.87% |
| SG&A Expenses | -3.84% | -4.72% | -8.64% | 6.25% | 4.06% |
| Depreciation & Amortization | 56.31% | 60.64% | 69.60% | 40.79% | 17.03% |
| Other Operating Expenses | 8.62% | 16.27% | 25.99% | 19.69% | 36.11% |
| Total Operating Expenses | -4.85% | -9.43% | -9.15% | 2.12% | 6.31% |
| Operating Income | 26.28% | 31.37% | 16.44% | -17.38% | -30.99% |
| Income Before Tax | 32.43% | 46.98% | 18.46% | -57.91% | -64.12% |
| Income Tax Expenses | 75.06% | 102.37% | 98.57% | -65.72% | -72.04% |
| Earnings from Continuing Operations | 26.73% | 40.53% | 10.42% | -56.57% | -62.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 366.67% | 242.86% | -333.33% |
| Net Income | 26.80% | 40.57% | 10.49% | -56.52% | -62.74% |
| EBIT | 26.28% | 31.37% | 16.44% | -17.38% | -30.99% |
| EBITDA | 27.85% | 32.35% | 19.46% | -11.46% | -25.27% |
| EPS Basic | 26.09% | 39.70% | 9.71% | -56.80% | -62.75% |
| Normalized Basic EPS | 25.46% | 24.11% | 1.60% | -23.84% | -31.67% |
| EPS Diluted | 26.31% | 40.06% | 9.99% | -56.78% | -62.81% |
| Normalized Diluted EPS | 25.69% | 24.31% | 1.79% | -23.69% | -31.68% |
| Average Basic Shares Outstanding | 0.60% | 0.59% | 0.59% | 0.50% | 0.14% |
| Average Diluted Shares Outstanding | 0.48% | 0.48% | 0.50% | 0.28% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |